Stacks Image 2648
TODD BIXBY
MAKING BIOTECHNOLOGY WORK
TECHNOLOGY ANALYST.
BUSINESS STRATEGIST.
NEW PRODUCT DEVELOPER.
PUBLIC HEALTH RESEARCHER.
Advancing biotechnologies for human health, biosecurity, food systems, and the environment for over 20 years.
Interested in opportunities to advise and work with science-based organizations and technology companies to:
  • Evaluate technology-based public health and environmental interventions in support of efforts to operationalize and scale
  • Advance strategies for businesses, technologies, and new product development

read more…
  • Advise on policy and technical considerations related to public health interventions leveraging biotechnology and synthetic biology
  • Provide technology scouting and technical diligence support for corporate development
  • Help realize breakthrough innovations promoting public health and safer environments
Stacks Image 2650
TODD BIXBY
MAKING BIOTECHNOLOGY WORK
TECHNOLOGY ANALYST. BUSINESS STRATEGIST. NEW PRODUCT DEVELOPER. PUBLIC HEALTH RESEARCHER.
Advancing biotechnologies for human health, biosecurity, food systems, and the environment for over 20 years.
Interested in opportunities to advise and work with science-based organizations and technology companies to:
  • Evaluate technology-based public health and environmental interventions in support of efforts to operationalize and scale
  • Advance strategies for businesses, technologies, and new product development
read more…
  • Advise on policy and technical considerations related to public health interventions leveraging biotechnology and synthetic biology
  • Provide technology scouting and technical diligence support for corporate development
  • Help realize breakthrough innovations promoting public health and safer environments
read more…
  • Advise on policy and technical considerations related to public health interventions leveraging biotechnology and synthetic biology
  • Provide technology scouting and technical diligence support for corporate development
  • Help realize breakthrough innovations promoting public health and safer environments
Stacks Image 3773
Stacks Image 3717
Stacks Image 3719
Stacks Image 3722
Stacks Image 3725
Stacks Image 3728
HEALTH
Targeted medicines and diagnostics
BIOSECURITY
Chemical and biological threat detection and countermeasures
FOOD SYSTEMS
Safe and sustainable food sources
ENVIRONMENT
Solutions to conserve, protect, clean, and revitalize the environment and promote biodiversity

OUR COMPANIES
WORKING TOGETHER TO CONNECT TECH DEVELOPERS & ADVISORS THAT REALIZE BIOTECHNOLOGY BREAKTHROUGHS
Stacks Image 3373
BIOTECHNOLOGY & PUBLIC HEALTH ADVISING
ROSSI BIXBY BIOTECHNOLOGY ADVISORS provides technology companies and science-based organizations specialized technical and business advising, as well a communications consulting to help solve big challenges impacting health, biosecurity, and the environment.
read more…
Established 2020. We also support emerging technology-based public health interventions by providing epidemiological, SDOH, and risk assessments, as well as technology analysis and product development advising. We currently have bandwidth to support new opportunities. Visit rossibixby.com to learn about our services.
Stacks Image 3433
TECHNOLOGY INCUBATOR
PLANETARY GENETICS is a genomics and biotechnology research and innovation engine focused on genomic analyses, generating intellectual property, and advancing development of core technologies. Our mission is to deliver platform technologies that help realize healthier people and a healthier planet.
read more…
The company was founded in 2019 to identify new technology opportunities, design and develop product prototypes, perform proof of concept studies, and advise venture teams.

Discover more at planetary-genetics.com.
Stacks Image 3449
BIOTECHNOLOGY & PUBLIC HEALTH ADVISING
ROSSI BIXBY BIOTECHNOLOGY ADVISORS provides technology companies and science-based organizations specialized technical and business advising, as well a communications consulting to help solve big challenges impacting health, biosecurity, and the environment.
Stacks Image 3481
TECHNOLOGY INCUBATOR
PLANETARY GENETICS is a genomics and biotechnology research and innovation engine focused on genomic analyses, generating intellectual property, and advancing development of core technologies. Our mission is to deliver platform technologies that help realize healthier people and a healthier planet.
read more…
The company was founded in 2019 to identify new technology opportunities, design and develop product prototypes, perform proof of concept studies, and advise venture teams.

Discover more at planetary-genetics.com.
BIOTECHNOLOGY & PUBLIC HEALTH ADVISING
Stacks Image 3500
ROSSI BIXBY BIOTECHNOLOGY ADVISORS provides technology companies and science-based organizations specialized technical and business advising, as well a communications consulting to help solve big challenges impacting health, biosecurity, and the environment.
read more…
Established 2020. We also support emerging technology-based public health interventions by providing epidemiological, SDOH, and risk assessments, as well as technology analysis and product development advising. We currently have bandwidth to support new opportunities. Visit rossibixby.com to learn about our services.
TECHNOLOGY INCUBATOR
Stacks Image 3543
PLANETARY GENETICS is a genomics and biotechnology research and innovation engine focused on genomic analyses, generating intellectual property, and advancing development of core technologies. Our mission is to deliver platform technologies that help realize healthier people and a healthier planet.
read more…
The company was founded in 2019 to identify new technology opportunities, design and develop product prototypes, perform proof of concept studies, and advise venture teams.

Discover more at planetary-genetics.com.

MAKING BIOTECHNOLOGY WORK FOR THE PUBLIC GOOD
MAKING BIOTECH WORK
FOR THE PUBLIC GOOD
CAREER HIGHLIGHTS
  • Developed current FDA-approved screening tests for safety of US blood supply, enabling transition from immunoassay to molecular tests for HIV, HCV, HBV, West Nile Virus (Gen-Probe)
  • Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test (Gen-Probe)
  • Developed national security multi-analyte threat detection systems against bioterrorism infectious agents for US Intelligence Community (Vectrant)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, and healthy air to reduce burden of chronic and infectious diseases (Central Malawi)
  • Served as technology analyst and business strategist at pioneering publicly-traded synthetic biology and genetic engineering company Intrexon, supporting C-suite and FORBES 400 largest individual American biotech investor. Advanced transformative biotechnologies across health, food, consumer, biosecurity, and environment sectors.
  • Helped establish Intrexon's pioneering environment sector leveraging synthetic biology and genetic engineering for infectious disease vector control, biosecurity, conservation, and bioremediation. Initiated development of gene-edited microbes for bioremediation of environmental contaminants of concern (i.e., 1,4-dioxane)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
  • Developed current FDA-approved screening tests for safety of US blood supply, enabling transition from immunoassay to molecular tests for HIV, HCV, HBV, West Nile Virus (Gen-Probe)
  • Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test (Gen-Probe)
  • Developed national security multi-analyte threat detection systems against bioterrorism infectious agents for US Intelligence Community (Vectrant)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, and healthy air to reduce burden of chronic and infectious diseases (Central Malawi)
  • Served as technology analyst and business strategist at pioneering publicly-traded synthetic biology and genetic engineering company Intrexon, supporting C-suite and FORBES 400 largest individual American biotech investor. Advanced transformative biotechnologies across health, food, consumer, biosecurity, and environment sectors.
  • Helped establish Intrexon's pioneering environment sector leveraging synthetic biology and genetic engineering for infectious disease vector control, biosecurity, conservation, and bioremediation. Initiated development of gene-edited microbes for bioremediation of environmental contaminants of concern (i.e., 1,4-dioxane)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
  • Developed current FDA-approved screening tests for safety of US blood supply, enabling transition from immunoassay to molecular tests for HIV, HCV, HBV, West Nile Virus (Gen-Probe)
  • Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test (Gen-Probe)
  • Developed national security multi-analyte threat detection systems against bioterrorism infectious agents for US Intelligence Community (Vectrant)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, and healthy air to reduce burden of chronic and infectious diseases (Central Malawi)
  • Served as technology analyst and business strategist at pioneering publicly-traded synthetic biology and genetic engineering company Intrexon, supporting C-suite and FORBES 400 largest individual American biotech investor. Advanced transformative biotechnologies across health, food, consumer, biosecurity, and environment sectors.
  • Helped establish Intrexon's pioneering environment sector leveraging synthetic biology and genetic engineering for infectious disease vector control, biosecurity, conservation, and bioremediation. Initiated development of gene-edited microbes for bioremediation of environmental contaminants of concern (i.e., 1,4-dioxane)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
ACADEMIC INTERESTS
Interested in opportunities to work with academics and organizations to:
  • Advance scientific understanding at the intersection of molecular epidemiology and systems biology using advanced biotechnologies
  • Evaluate technology platforms for utility in public health and environmental interventions and make recommendations to help operationalize and scale
  • Support molecular epidemiology studies of genetic and epigenetic determinants of disease to identify risk factors and elucidate correlation of health or disease-states to epigenetic signatures from behaviors, environmental exposures, and drug regimens
  • Study the impacts of environmental pollution on community health and synthesize scientific data to inform or recommend better public health policy to address health promotion and environmental justice
  • Study health outcomes associated with environmental contaminant of concern exposures and associated social and ecological determinants of health disparities, inequities, and inequalities
  • Support thought leadership for transformational uses of biotechnology to improve public health
Interested in opportunities to work with academics and organizations to:
  • Advance scientific understanding at the intersection of molecular epidemiology and systems biology using advanced biotechnologies
  • Evaluate technology platforms for utility in public health and environmental interventions and make recommendations to help operationalize and scale
  • Support molecular epidemiology studies of genetic and epigenetic determinants of disease to identify risk factors and elucidate correlation of health or disease-states to epigenetic signatures from behaviors, environmental exposures, and drug regimens
  • Study the impacts of environmental pollution on community health and synthesize scientific data to inform or recommend better public health policy to address health promotion and environmental justice
  • Study health outcomes associated with environmental contaminant of concern exposures and associated social and ecological determinants of health disparities, inequities, and inequalities
  • Support thought leadership for transformational uses of biotechnology to improve public health
FORMER AFFILIATIONS
COMPANIES
  • Intrexon | pioneering synthetic biology and genetic engineering company
  • Exonhit Therapeutics | microarray molecular diagnostics for chronic disease and genetic variant screening
  • Vectrant Technologies | biodefense threat detection systems and infectious disease medical diagnostics
  • Nanogen | microarray molecular diagnostics and immunoassays for chronic and infectious diseases
  • Gen-Probe | molecular tests for screening US blood supply and clinical diagnostics for infectious diseases
  • Intrexon | pioneering synthetic biology and genetic engineering company
  • Exonhit Therapeutics | microarray molecular diagnostics for chronic disease and genetic variant screening
  • Vectrant Technologies | biodefense threat detection systems and infectious disease medical diagnostics
  • Nanogen | microarray molecular diagnostics and immunoassays for chronic and infectious diseases
  • Gen-Probe | molecular tests for screening US blood supply and clinical diagnostics for infectious diseases
ACADEMIC RESEARCH INSTITUTIONS
  • George Mason University, Department of Global and Community Health | master of public health graduate studies in epidemiology (program pending completion)
  • UCSD Scripps Institution of Oceanography, Marine Biology Research Division | independent research: environmental and extremophilic microbiology natural products chemistries for molecular tools, medicines, and bioremediation
  • The Scripps Research Institute, Department of Immunology | immunology basic research focused on virology, cancer, and Alzheimer's disease during undergraduate studies
  • University of California San Diego, Department of Biology | undergraduate studies in biology
  • George Mason University, Department of Global and Community Health | master of public health graduate studies in epidemiology (program pending completion)
  • UCSD Scripps Institution of Oceanography, Marine Biology Research Division | independent research: environmental and extremophilic microbiology natural products chemistries for molecular tools, medicines, and bioremediation
  • The Scripps Research Institute, Department of Immunology | immunology basic research focused on virology, cancer, and Alzheimer's disease during undergraduate studies
  • University of California San Diego, Department of Biology | undergraduate studies in biology
VOLUNTEER ORGANIZATIONS
  • American Lung Association | Supported Healthy Air Campaign and briefings to US Congress on program activities
  • St. Gabriel's Hospital - Lilongwe District, Malawi | Performed global health fieldwork and international development with interventions targeting HIV, malaria, and healthy air to reduce burden of chronic diseases
  • American Lung Association | Supported Healthy Air Campaign and briefings to US Congress on program activities
  • St. Gabriel's Hospital - Lilongwe District, Malawi | Performed global health fieldwork and international development with interventions targeting HIV, malaria, and healthy air to reduce burden of chronic diseases
PROFILES
BIOSKETCH
TODD BIXBY
TODD BIXBY
Mr. Bixby is a biotechnology developer, technology analyst, business and corporate strategist, and public health innovator with over 20 years experience advancing biotechnologies to promote healthier communities and environments. He has worked to develop and deploy advanced technologies for human health, environmental health, biosecurity, biodefense, sustainable food production, consumer products, and conservation.

He developed groundbreaking FDA-cleared products including current molecular tests for safety screening of the U.S. blood supply (HIV, HCV, HBV, West Nile virus) and launched the APTIMA molecular diagnostics platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test. He also participated in the deployment of pioneering mobile HIV / CD4 diagnostics for low resource settings in Sub-Saharan Africa. He has deep experience advancing several synthetic biology and genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered products regulated by FDA, USDA, and EPA. He remains dedicated to developing medicines, biothreat detection systems, and environmental interventions aimed at improving global public health and biosecurity.

Mr. Bixby, a San Diego native and graduate of the University of California San Diego, is currently advising biotechnology startups and establishing new ventures focused on realizing healthier people and healthier environments.
Mr. Bixby is a biotechnology developer, technology analyst, business and corporate strategist, and public health innovator with over 20 years experience advancing biotechnologies to promote healthier communities and environments. He has worked to develop and deploy advanced technologies for human health, environmental health, biosecurity, biodefense, sustainable food production, consumer products, and conservation.

He developed groundbreaking FDA-cleared products including current molecular tests for safety screening of the U.S. blood supply (HIV, HCV, HBV, West Nile virus) and launched the APTIMA molecular diagnostics platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test. He also participated in the deployment of pioneering mobile HIV / CD4 diagnostics for low resource settings in Sub-Saharan Africa. He has deep experience advancing several synthetic biology and genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered products regulated by FDA, USDA, and EPA. He remains dedicated to developing medicines, biothreat detection systems, and environmental interventions aimed at improving global public health and biosecurity.

Mr. Bixby, a San Diego native and graduate of the University of California San Diego, is currently advising biotechnology startups and establishing new ventures focused on realizing healthier people and healthier environments.
MULTI-DISCIPLINARY EXPERTISE
BIOTECH EXPERTISE & EXPERIENCE
  • New Product Development and Commercialization
  • Technology Analysis
  • Corporate Development M&A Diligence
  • Business & Corporate Strategy
  • Marketing and Branding
  • Business Development
  • Strategic and Technical Communications
  • Basic and Applied Research
  • Public Health and Global Health Interventions
  • Government Relations
  • Not-for-Profit and Philanthropic Funder Engagements
MARKETING & DEVELOPMENT EXPERIENCE
HEALTH, BIOSECURITY, FOOD & ENVIRONMENT SECTORS
  • Medical diagnostics
  • Environmental biosecurity threat detection
  • Bioremediation and environmental cleanup of chemical contaminants of concern (COCs)
  • Infectious disease vector control using genetic engineering technologies
  • Vaccines and therapeutics
  • Sustainable food and protein production using gene editing and genetic engineering technologies
Specialized fields and disciplines
  • Biotechnology Development
  • Medical Devices and Healthcare Technologies
  • Synthetic Biology and Genetic Engineering
  • Public Health
  • Global Health
  • Epidemiology
  • Biosecurity and Biodefense
  • Environmental Health
SOCIAL MEDIA
TODD BIXBY
TODD BIXBY
PLANETARY GENETICS
PLANETARY GENETICS
ROSSI BIXBY + ASSOCIATES | BIOTECHNOLOGY & COMMUNICATIONS CONSULTING
ROSSI BIXBY + ASSOCIATES | BIOTECHNOLOGY & COMMUNICATIONS CONSULTING

ADVANCING BIOTECHNOLOGY
FOR HEALTHIER PEOPLE AND
A HEALTHIER PLANET

ADVANCING BIOTECHNOLOGY FOR
HEALTHIER PEOPLE AND A HEALTHIER PLANET

Stacks Image 2751
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein
Stacks Image 3700
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein
Learn more about my MISSION
Learn more about my MISSION